Your browser doesn't support javascript.
loading
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Mazurek, Michal; Teutsch, Christine; Diener, Hans-Christoph; Dubner, Sergio J; Halperin, Jonathan L; Ma, Chang-Sheng; Rothman, Kenneth J; Paquette, Miney; Zint, Kristina; França, Lionel Riou; Lu, Shihai; Bartels, Dorothee B; Huisman, Menno V; Lip, Gregory Y H.
Afiliación
  • Mazurek M; Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland.
  • Teutsch C; Department of Clinical Development and Medical Affairs, Therapeutic Area Cardiometabolism, Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Diener HC; Department of Neurology, University of Duisburg-Essen, Essen, Germany.
  • Dubner SJ; Clínica y Maternidad Suizo Argentina, Buenos Aires, Argentina.
  • Halperin JL; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Ma CS; Cardiology Department, Atrial Fibrillation Center, Beijing AnZhen Hospital, Capital Medical University, Beijing, China.
  • Rothman KJ; RTI Health Solutions, Research Triangle Park, NC.
  • Paquette M; Department of Medicine, Boehringer Ingelheim, Burlington, ON, Canada.
  • Zint K; Global Epidemiology Department, Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • França LR; Sanofi-Aventis, Chilly-Mazarin, France.
  • Lu S; Biostatistics and Data Sciences Department, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT.
  • Bartels DB; Global Epidemiology Department, Boehringer Ingelheim International GmbH, Ingelheim, Germany; Hannover Medical School, Hannover, Germany.
  • Huisman MV; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom. Electronic address: Gregory.Lip@liverpool.ac.uk.
Am Heart J ; 218: 123-127, 2019 12.
Article en En | MEDLINE | ID: mdl-31806087
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Sistema de Registros / Antitrombinas / Accidente Cerebrovascular / Dabigatrán Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2019 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Sistema de Registros / Antitrombinas / Accidente Cerebrovascular / Dabigatrán Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am Heart J Año: 2019 Tipo del documento: Article País de afiliación: Polonia